SciRhom

About:

SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.

Website: https://scirhom.com/

Top Investors: Andera Partners, HTGF | High-Tech Gruenderfonds, Hospital for Special Surgery, Bayern Kapital, Wellington Partners

Description:

SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academic and industry scientists with profound experience in antibody development.

Total Funding Amount:

78M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Martinsried, Bayern, Germany

Founded Date:

2016-01-01

Contact Email:

info(AT)SciRhom.com

Founders:

Andreas Jenne, Jens Ruhe, Matthias Schneider

Number of Employees:

1-10

Last Funding Date:

2024-07-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai